HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.

AbstractBACKGROUND:
A cross-study analysis of contraceptive clinical trials for two different 91-day oral contraceptive (OC) regimens was performed to examine the impact on bleeding patterns when supplementing the 7-day hormone-free interval with 10 mcg ethinyl estradiol (EE) daily.
STUDY DESIGN:
Two separate 1-year Phase 3 clinical programs were conducted using similar study designs. The percentages of subjects reporting bleeding and spotting using electronic diaries for each 91-day cycle were compared.
RESULTS:
Scheduled bleeding with the EE regimen was less than that reported with the regimen utilizing placebo during Days 85-91, with significant differences noted for all four 91-day cycles. Unscheduled bleeding decreased more quickly with the 91-day regimen containing low-dose EE in place of placebo, with significant differences noted during the third cycle.
CONCLUSIONS:
This cross-study comparison suggests that the administration of low-dose estrogen in place of placebo in a 91-day extended regimen OC improves the bleeding profile.
AuthorsAndrew M Kaunitz, David J Portman, Howard Hait, Kathleen Z Reape
JournalContraception (Contraception) Vol. 79 Issue 5 Pg. 350-5 (May 2009) ISSN: 1879-0518 [Electronic] United States
PMID19341846 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contraceptives, Oral, Hormonal
  • Estrogens
  • Seasonale
  • Ethinyl Estradiol
  • Levonorgestrel
  • Ethinyl Estradiol-Norgestrel Combination
Topics
  • Adult
  • Clinical Trials as Topic
  • Contraceptives, Oral, Hormonal (administration & dosage)
  • Estrogens (administration & dosage, adverse effects)
  • Ethinyl Estradiol (administration & dosage, adverse effects)
  • Ethinyl Estradiol-Norgestrel Combination (administration & dosage, adverse effects)
  • Female
  • Humans
  • Levonorgestrel (administration & dosage, adverse effects)
  • Menstruation (drug effects)
  • Metrorrhagia (chemically induced)
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: